92 related articles for article (PubMed ID: 19297281)
1. Emergence of a plasmid mediated bla (VIM-1) in Citrobacter koseri: report from the SENTRY Antimicrobial Surveillance Program (Italy).
Castanheira M; Debbia E; Marchese A; Jones RN
J Chemother; 2009 Feb; 21(1):98-100. PubMed ID: 19297281
[No Abstract] [Full Text] [Related]
2. Detection of an IncA/C plasmid encoding VIM-4 and CMY-4 β-lactamases in Klebsiella oxytoca and Citrobacter koseri from an inpatient in a cardiac rehabilitation unit.
Caltagirone M; Bitar I; Piazza A; Spalla M; Nucleo E; Navarra A; Migliavacca R
New Microbiol; 2015 Jul; 38(3):387-92. PubMed ID: 26147151
[TBL] [Abstract][Full Text] [Related]
3. Characterization of the chromosomal class A beta-lactamase CKO from Citrobacter koseri.
Petrella S; Renard M; Ziental-Gelus N; Clermont D; Jarlier V; Sougakoff W
FEMS Microbiol Lett; 2006 Jan; 254(2):285-92. PubMed ID: 16445758
[TBL] [Abstract][Full Text] [Related]
4. First genome sequence of a bla
Hu X; Xu H; Shang Y; Guo L; Song L; Zhang H; Yue F; Jiang H; Zheng B
J Glob Antimicrob Resist; 2018 Dec; 15():166-168. PubMed ID: 30291901
[TBL] [Abstract][Full Text] [Related]
5. Novel TEM-type extended-spectrum beta-lactamase, TEM-134, in a Citrobacter koseri clinical isolate.
Perilli M; Mugnaioli C; Luzzaro F; Fiore M; Stefani S; Rossolini GM; Amicosante G
Antimicrob Agents Chemother; 2005 Apr; 49(4):1564-6. PubMed ID: 15793140
[TBL] [Abstract][Full Text] [Related]
6. Genome sequence of carbapenem-resistant Citrobacter koseri carrying bla
Ekwanzala MD; Dewar JB; Kamika I; Momba MNB
J Glob Antimicrob Resist; 2020 Mar; 20():94-97. PubMed ID: 31323426
[TBL] [Abstract][Full Text] [Related]
7. A nosocomial outbreak due to novel CTX-M-2-producing strains of Citrobacter koseri in a hematological ward.
Muta T; Tsuruta N; Seki Y; Ota R; Suzuki S; Shibata N; Kato K; Eto T; Gondo H; Arakawa Y
Jpn J Infect Dis; 2006 Feb; 59(1):69-71. PubMed ID: 16495644
[No Abstract] [Full Text] [Related]
8. Dissemination of a bla(VIM-2)-carrying integron among Enterobacteriaceae species in Mexico: report from the SENTRY Antimicrobial Surveillance Program.
Morfin-Otero R; Rodriguez-Noriega E; Deshpande LM; Sader HS; Castanheira M
Microb Drug Resist; 2009 Mar; 15(1):33-5. PubMed ID: 19228113
[TBL] [Abstract][Full Text] [Related]
9. Detection of Citrobacter koseri carrying beta-lactamase KPC-2 in a hospitalised patient, Greece, July 2011.
Mavroidi A; Neonakis I; Liakopoulos A; Papaioannou A; Ntala M; Tryposkiadis F; Miriagou V; Petinaki E
Euro Surveill; 2011 Oct; 16(41):. PubMed ID: 22008199
[TBL] [Abstract][Full Text] [Related]
10. Citrobacter koseri and Citrobacter amalonaticus isolates carry highly divergent beta-lactamase genes despite having high levels of biochemical similarity and 16S rRNA sequence homology.
Underwood S; Avison MB
J Antimicrob Chemother; 2004 Jun; 53(6):1076-80. PubMed ID: 15128725
[TBL] [Abstract][Full Text] [Related]
11. Optimum management of Citrobacter koseri infection.
Deveci A; Coban AY
Expert Rev Anti Infect Ther; 2014 Sep; 12(9):1137-42. PubMed ID: 25088467
[TBL] [Abstract][Full Text] [Related]
12. High prevalence of extended-spectrum β-lactamases and qnr determinants in Citrobacter species from Japan: dissemination of CTX-M-2.
Kanamori H; Yano H; Hirakata Y; Endo S; Arai K; Ogawa M; Shimojima M; Aoyagi T; Hatta M; Yamada M; Nishimaki K; Kitagawa M; Kunishima H; Kaku M
J Antimicrob Chemother; 2011 Oct; 66(10):2255-62. PubMed ID: 21733965
[TBL] [Abstract][Full Text] [Related]
13. Italian metallo-beta-lactamases: a national problem? Report from the SENTRY Antimicrobial Surveillance Programme.
Toleman MA; Biedenbach D; Bennett DM; Jones RN; Walsh TR
J Antimicrob Chemother; 2005 Jan; 55(1):61-70. PubMed ID: 15574470
[TBL] [Abstract][Full Text] [Related]
14. CTX-M-35 extended-spectrum beta-lactamase conferring ceftazidime resistance in Citrobacter koseri.
Tian GB; Adams-Haduch JM; Qureshi ZA; Wang HN; Doi Y
Int J Antimicrob Agents; 2010 Apr; 35(4):412-3. PubMed ID: 20138478
[No Abstract] [Full Text] [Related]
15. SHV-34: an extended-spectrum beta-lactamase encoded by an epidemic plasmid.
Heritage J; Chambers PA; Tyndall C; Buescher ES
J Antimicrob Chemother; 2003 Dec; 52(6):1015-7. PubMed ID: 14613945
[TBL] [Abstract][Full Text] [Related]
16. Dissemination and diversity of metallo-beta-lactamases in Latin America: report from the SENTRY Antimicrobial Surveillance Program.
Sader HS; Castanheira M; Mendes RE; Toleman M; Walsh TR; Jones RN
Int J Antimicrob Agents; 2005 Jan; 25(1):57-61. PubMed ID: 15620827
[TBL] [Abstract][Full Text] [Related]
17. Antimicrobial resistance in Salmonella enteritidis, southern Italy, 1990-1998.
Nastasi A; Mammina C; Cannova L
Emerg Infect Dis; 2000; 6(4):401-3. PubMed ID: 10905977
[TBL] [Abstract][Full Text] [Related]
18. Prevalence of β-lactamases and 16S rRNA methylase genes amongst clinical Klebsiella pneumoniae isolates carrying plasmid-mediated quinolone resistance determinants.
Luo Y; Yang J; Zhang Y; Ye L; Wang L; Guo L
Int J Antimicrob Agents; 2011 Apr; 37(4):352-5. PubMed ID: 21376540
[TBL] [Abstract][Full Text] [Related]
19. Complex clonal and plasmid epidemiology in the first outbreak of Enterobacteriaceae infection involving VIM-1 metallo-beta-lactamase in Spain: toward endemicity?
Tato M; Coque TM; Ruíz-Garbajosa P; Pintado V; Cobo J; Sader HS; Jones RN; Baquero F; Cantón R
Clin Infect Dis; 2007 Nov; 45(9):1171-8. PubMed ID: 17918078
[TBL] [Abstract][Full Text] [Related]
20. First characterisation of plasmid-mediated quinolone resistance-qnrS1 co-expressed bla CTX-M-15 and bla DHA-1 genes in clinical strain of Morganella morganii recovered from a Tunisian Intensive Care Unit.
Mahrouki S; Bourouis A; Chihi H; Ouertani R; Ferjani M; Moussa MB; Barguellil F; Belhadj O
Indian J Med Microbiol; 2012; 30(4):437-41. PubMed ID: 23183469
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
